Abstract
The SARS coronavirus main proteinase is a prime target for antiviral therapy. In this issue of Chemistry & Biology, Wu et al. describe potent inhibition of the enzyme by benzotriazole esters, which were originally obtained as intermediates in the synthesis of lopinavir derivatives [1].
| Original language | English |
|---|---|
| Journal | Chemistry and Biology |
| Volume | 13 |
| Issue number | 3 |
| Pages (from-to) | 235-236 |
| Number of pages | 2 |
| ISSN | 1074-5521 |
| DOIs | |
| Publication status | Published - 01.03.2006 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research Areas and Centers
- Academic Focus: Center for Infection and Inflammation Research (ZIEL)
Coronavirus related work
- Research on SARS-CoV-2 / COVID-19
Fingerprint
Dive into the research topics of 'Sometimes Intermediates Do the Job!'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver